Despite its potential, BPC 157s lack of extensive human studies and FDA approval highlights the need for further research to establish its safety and efficacy
FIGURE 2 In contrast, with the administration of L-NAME, there was a moderate generalized irregularity in the diameter of blood vessels with moderate atrophy of the optic disc, faint presentation of the choroidal blood vessels appears immediately, and these lesions (Figure 2, IN, IIN) rapidly progress (Figure 3, AC
Results vary based on individual metabolism, dosage, frequency, and lifestyle habits
The Tight Budgets Argument: You are right that the cost of the injection and the nurses time is the same regardless of the day
Monitor closely: Track healing, inflammation and any side effects with physician oversight